Patient Monitors (ICU) in New York

Retia Medical Systems develops cardiovascular surveillance software and hemodynamic monitoring solutions for intensive care, operating rooms, and perioperative environments. The company's core offering is the Argos® Cardiac Output Monitor, a bedside hemodynamic monitoring device that derives reliable cardiac output and cardiovascular insight from routine physiologic signals without requiring proprietary disposable sensors. The Argos Infinity™ platform extends this capability enterprise-wide, deploying the company's Multi-Beat Analysis (MBA) algorithm across hospital systems and tele-ICU environments to enable centralized cardiovascular surveillance and analytics. Retia's technology is designed to detect hemodynamic instability earlier than traditional vital sign monitoring, particularly in complex scenarios including arrhythmia, cardiogenic shock, low-flow states, and unstable blood pressure. The software integrates with existing monitoring and tele-ICU platforms, transforming real-time physiologic data into actionable clinical intelligence. Deployed in 75+ hospitals including major academic medical centers (Johns Hopkins, Duke Health, Cleveland Clinic, University Hospitals Cleveland, Texas Health Resources, UMC Health System, Rabin Medical Center), the solution has been validated in 14 peer-reviewed clinical studies. Retia received FDA 510(k) clearance for Argos Infinity. The company targets high-risk populations including cardiac and vascular surgery, sepsis, transplant, trauma, burns, and neurocritical care. Primary value propositions include elimination of disposable sensor costs, intuitive bedside workflow design, and system-wide scalability without infrastructure burden.

ImaCor Inc develops hemodynamic ultrasound systems for critical care settings, with primary focus on transesophageal echocardiography (TEE) for ICU, cardiac surgery, surgical/trauma, and intensive care units. The company's Hemodynamic Ultrasound platform enables direct visualization of cardiac filling and function over time to assess and guide interventions for critically ill patients. Core products include the Zura Handheld device and ClariTEE Probe, deployed via the proprietary hTEE 3-Step Method. This method combines gold-standard transesophageal echo practices with critical care protocols, allowing visualization of transgastric short axis, midesophageal four chamber, and SVC views. Clinical evidence indicates hTEE made direct therapeutic impact in 66% of patients and improved hemodynamics in 80% of cases. Primary clinical applications include fluid management and preload assessment, cardiac surgery support, trauma resuscitation, LVAD (left ventricular assist device) monitoring, and differentiation of cardiac tamponade from other causes of hemodynamic compromise. The company serves surgeons, intensivists, nurse practitioners, and trauma program managers across CVICU, SICU, MICU, and ED settings. ImaCor provides comprehensive educational support including whiteboard lessons, learning modules, case studies, peer-reviewed evidence, and 24/7 technical support. The platform addresses critical gaps in bedside cardiac assessment beyond traditional indirect methods such as blood pressure, lactate, and cardiac output monitoring.

BioSignal is a neurodiagnostic company specializing in functional brain assessment via portable EEG technology. The company's FDA-approved microEEG® solution is a miniature, wireless clinical platform enabling rapid electroencephalogram (EEG) recording with cloud-based remote interpretation. BioSignal serves traditional neurology settings (epilepsy centers, sleep labs, neurology departments, ICUs) and expands brain function assessment into novel environments including emergency departments, NICUs, physician offices, ambulances, and home care. The platform supports sports concussion management, traumatic brain injury assessment, routine EEG monitoring, and STAT EEG capabilities. Applications span clinical neurology, emergency medicine, pediatric critical care, sleep medicine, sports medicine, and home sleep monitoring. The solution combines hardware portability with interpretive software to enable rapid assessment and telemedicine-capable EEG interpretation.

CEIBA Health Technologies is an AI-powered healthcare technology platform specializing in virtual clinical care and medical device connectivity solutions. The company delivers an integrated Enterprise Suite with four core capabilities: (1) IoMT Interoperability—featuring a plug-and-play IoMT Box with 1,000+ pre-installed device drivers supporting 20+ EHR integrations; (2) Continuous Monitoring—delivering real-time telemetry dashboards for patient monitors, ventilators, infusion pumps, blood gas analyzers, and EEG machines across ICU, med-surge, LTACH, and SNF settings; (3) Decision Support & Workflow—providing actionable clinical insights and operational dashboards; and (4) Virtual Clinical Care—a telehealth platform enabling multi-specialty consultations, remote rounding, and acute care at home. CEIBA's protocol-agnostic architecture supports HL7, FHIR, JSON, and XML with enterprise-grade security, encrypted data transfer, and full mobile functionality. The platform is designed for rapid deployment (days vs. months) and serves hospitals and health systems in the US and internationally.

Veris Health is a digital health platform specializing in personalized cancer care through remote patient monitoring and clinical connectivity. As a majority-owned subsidiary of PAVmed Inc., the company delivers the Veris Cancer Care Platform—a cloud-based solution enabling continuous bidirectional communication between patients and oncology care teams. The platform integrates physiological data collection via VerisBox™ connected devices, symptom tracking, secure messaging, and scheduled video consultations with EHR interoperability. Features include real-time trend analysis, quality-of-life assessments using EQ-5D™, automated reimbursement documentation, and family/caregiver engagement tools. Available on iOS and Android with Spanish-language support. The platform is HIPAA and SOC compliant and aligns with value-based care models including CMS's Enhancing Oncology Model (EOM). Designed for oncology practices, hospital systems, and cancer centers seeking to improve patient engagement and clinical outcomes through remote monitoring.